Elevance Health Executive Compensation Details Revealed

Ticker: ELV · Form: DEF 14A · Filed: 2025-03-28T00:00:00.000Z

Sentiment: neutral

Topics: proxy-statement, executive-compensation, equity-awards

TL;DR

Elevance Health dropped its proxy statement detailing exec pay for 2024. Shareholders get the scoop on stock awards.

AI Summary

Elevance Health, Inc. filed its DEF 14A on March 28, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to its principal executive officer (PEO) and non-PEO named executive officers, with details on the value of outstanding and unvested awards as of the end of the fiscal year.

Why It Matters

This filing provides shareholders with crucial information regarding how executive compensation is structured and awarded, impacting corporate governance and investor confidence.

Risk Assessment

Risk Level: low — This is a routine annual filing providing information on executive compensation and is not indicative of immediate financial risk.

Key Numbers

2024 — Fiscal Year (Compensation details are for this year.)
2023 — Prior Fiscal Year (Comparative data may be included.)

Key Players & Entities

Elevance Health, Inc. (company) — Filer of the DEF 14A
2024-12-31 (date) — Fiscal year end for compensation details
20250328 (date) — Filing date of the DEF 14A
20250514 (date) — Conformed period of report

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, including the election of directors and executive compensation.

Who are the named executive officers for whom compensation details are provided?

The filing provides details for the Principal Executive Officer (PEO) and Non-PEO Named Executive Officers, with specific individuals like Boudreaux, Kaye, Haytaian, Norwood, and Kendrick mentioned in relation to award dates.

What types of equity awards are discussed in the filing?

The filing discusses equity awards granted in covered years that are outstanding and unvested at the end of the fiscal year, specifically for PEO and Non-PEO members.

When was Elevance Health, Inc. previously known as Anthem, Inc.?

Elevance Health, Inc. was formerly known as Anthem, Inc. with a date of name change on December 2, 2014.

What is the business address and phone number for Elevance Health, Inc.?

The business address is 220 Virginia Avenue, Indianapolis, IN 46204, and the business phone number is 800-331-1476.

From the Filing

0001156039-25-000046.txt : 20250328 0001156039-25-000046.hdr.sgml : 20250328 20250328162035 ACCESSION NUMBER: 0001156039-25-000046 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 122 CONFORMED PERIOD OF REPORT: 20250514 FILED AS OF DATE: 20250328 DATE AS OF CHANGE: 20250328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc. CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 25786620 BUSINESS ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 8003311476 MAIL ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: Anthem, Inc. DATE OF NAME CHANGE: 20141202 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT, INC DATE OF NAME CHANGE: 20100105 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 DEF 14A 1 elv-20250328.htm DEF 14A elv-20250328 0001156039 DEF 14A FALSE xbrli:shares iso4217:USD xbrli:shares iso4217:USD xbrli:pure 0001156039 2024-01-01 2024-12-31 0001156039 elv:BoudreauxMember 2024-03-01 0001156039 elv:KayeMember 2024-03-01 0001156039 elv:HaytaianMember 2024-03-01 0001156039 elv:NorwoodMember 2024-03-01 0001156039 elv:KendrickMember 2024-03-01 0001156039 2023-01-01 2023-12-31 0001156039 2022-01-01 2022-12-31 0001156039 2021-01-01 2021-12-31 0001156039 2020-01-01 2020-12-31 0001156039 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2024-01-01 2024-12-31 0001156039 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001156039 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2024-01-01 2024-12-31 0001156039 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001156039 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:PeoMember 2024-01-01 2024-12-31 0001156039 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001156039 elv:EquityAwardsGrantedDuringTheYearVestedMember ecd:PeoMember 2024-01-01 2024-12-31 0001156039 elv:EquityAwardsGrantedDuringTheYearVestedMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001156039 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:PeoMember 2024-01-01 2024-12-31 0001156039 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001156039 elv:EquityAwardsThatFailedToMeetVestingConditionsMember ecd:PeoMember 2024-01-01 2024-12-31 0001156039 elv:EquityAwardsThatFailedToMeetVestingConditionsMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001156039 elv:EquityAwardsValueOfDividendsAndOtherEarningsPaidAdjustmentMember ecd:PeoMember 2024-01-01 2024-12-31 0001156039 elv:EquityAwardsValueOfDividendsAndOtherEarningsPaidAdjustmentMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001156039 ecd:AggtChngPnsnValInSummryCompstnTblForAplblYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001156039 1 2024-01-01 2024-12-31 0001156039 2 2024-01-01 2024-12-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☑ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under §240.14a-12 Elevance Health, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) PAYMENT